Published in Infect Immun on October 01, 2003
Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect Immun (2005) 1.13
Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun (2008) 1.04
Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice. Infect Immun (2006) 1.00
Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting. Clin Vaccine Immunol (2007) 0.94
An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. PLoS One (2011) 0.93
Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge. Vaccine (2010) 0.85
Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis. Front Cell Infect Microbiol (2013) 0.82
In silico analysis of chimeric TF, Omp31 and BP26 fragments of Brucella melitensis for development of a multi subunit vaccine candidate. Iran J Basic Med Sci (2014) 0.82
Recent advances in Brucella abortus vaccines. Vet Res (2015) 0.81
Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria. Clin Vaccine Immunol (2007) 0.81
Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice. J Vet Sci (2012) 0.80
Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera. Infect Immun (2014) 0.80
A polymeric protein induces specific cytotoxicity in a TLR4 dependent manner in the absence of adjuvants. PLoS One (2012) 0.80
Literature Mining and Ontology based Analysis of Host-Brucella Gene-Gene Interaction Network. Front Microbiol (2015) 0.79
Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella. Protein Sci (2017) 0.75
Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit. Clin Vaccine Immunol (2008) 0.75
Comparison between Immunization Routes of Live Attenuated Salmonella Typhimurium Strains Expressing BCSP31, Omp3b, and SOD of Brucella abortus in Murine Model. Front Microbiol (2016) 0.75
Meta-Analysis and Advancement of Brucellosis Vaccinology. PLoS One (2016) 0.75
Expression of the Multimeric and Highly Immunogenic Brucella spp. Lumazine Synthase Fused to Bovine Rotavirus VP8d as a Scaffold for Antigen Production in Tobacco Chloroplasts. Front Plant Sci (2015) 0.75
Human brucellosis. Rev Infect Dis (1983) 5.10
Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol (1991) 4.67
Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J Immunol (1989) 2.73
Brucellosis vaccines: past, present and future. Vet Microbiol (2002) 2.25
Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect Immun (1993) 2.24
Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology (2001) 1.74
Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine (1996) 1.70
Interleukin-10 downregulates protective immunity to Brucella abortus. Infect Immun (1995) 1.68
Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol (1999) 1.66
Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum. Infect Immun (1990) 1.56
The influence of virus structure on antibody responses and virus serotype formation. Immunol Today (1996) 1.50
Determinants of autoantibody induction by conjugated papillomavirus virus-like particles. J Immunol (2002) 1.48
Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro. Infect Immun (2000) 1.36
Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis. J Clin Microbiol (1993) 1.34
Pathogenesis and cellular immunity in experimental murine brucellosis. Dev Biol Stand (1984) 1.32
Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine (1994) 1.32
A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J Immunol (1999) 1.17
Impaired control of Brucella melitensis infection in Rag1-deficient mice. Infect Immun (2000) 1.11
A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun (2002) 1.11
Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9. Clin Diagn Lab Immunol (1996) 1.07
Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine. Vaccine (1997) 1.06
Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect Immun (2001) 1.05
Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella. J Med Microbiol (1992) 1.04
Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis. J Med Microbiol (1995) 1.01
Persistence of Brucella abortus in the livers of T cell-deficient nude mice. Lab Invest (1995) 0.99
Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection. Infect Immun (2001) 0.97
Diagnosis of canine brucellosis by detection of serum antibodies against an 18 kDa cytoplasmic protein of Brucella spp. Vet Microbiol (1997) 0.97
Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response. Exp Parasitol (1996) 0.96
The 18-kDa cytoplasmic protein of Brucella species --an antigen useful for diagnosis--is a lumazine synthase. J Med Microbiol (1999) 0.91
Divergence in macromolecular assembly: X-ray crystallographic structure analysis of lumazine synthase from Brucella abortus. J Mol Biol (2000) 0.89
Identification and partial characterisation of a new protective antigen of Brucella abortus. J Med Microbiol (2000) 0.89
Regulation of cytokine gene expression by adjuvants in vivo. Clin Exp Immunol (1997) 0.88
Immunons revisited: binding of multivalent antigens to B cells. Mol Immunol (1997) 0.87
Determination of cytokine co-expression in individual splenic CD4+ and CD8+ T cells from influenza virus-immune mice. Immunology (1998) 0.81
Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice. Vaccine (1999) 0.79
Structural, functional and immunological studies on a polymeric bacterial protein. Braz J Med Biol Res (2000) 0.77
Sublingual immunotherapy for allergic respiratory diseases: an evaluation of meta-analyses. J Allergy Clin Immunol (2009) 2.78
Blue-light-activated histidine kinases: two-component sensors in bacteria. Science (2007) 2.65
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol (2009) 1.94
Major outer membrane proteins of Brucella spp.: past, present and future. Vet Microbiol (2002) 1.65
Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J Immunol (2004) 1.52
A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Infect Immun (2005) 1.16
Immunofluorescence detection of globotriaosylceramide deposits in conjunctival biopsies of Fabry disease patients. Clin Experiment Ophthalmol (2006) 1.13
Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Vaccine (2007) 1.13
Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect Immun (2005) 1.13
Proinflammatory response of human endothelial cells to Brucella infection. Microbes Infect (2011) 1.13
A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun (2002) 1.11
The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice. Microbes Infect (2003) 1.10
Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis. J Infect Dis (2002) 1.09
Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae. Clin Diagn Lab Immunol (2004) 1.05
A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice. Infect Immun (2006) 1.05
Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun (2008) 1.04
Structural mechanism for affinity maturation of an anti-lysozyme antibody. Proc Natl Acad Sci U S A (2004) 1.03
Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo. FASEB J (2007) 1.00
High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase. J Biol Chem (2003) 0.99
Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2. Infect Immun (2007) 0.99
Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis. Am J Pathol (2010) 0.96
Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis. Vet Microbiol (2004) 0.95
Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide. Mol Genet Metab (2013) 0.95
A polymeric bacterial protein activates dendritic cells via TLR4. J Immunol (2006) 0.94
Proinflammatory response of human osteoblastic cell lines and osteoblast-monocyte interaction upon infection with Brucella spp. Infect Immun (2008) 0.94
Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting. Clin Vaccine Immunol (2007) 0.94
Suture rupture in acromioclavicular joint dislocations treated with flip buttons. Arthroscopy (2011) 0.94
An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. PLoS One (2011) 0.93
Granulocyte-macrophage colony-stimulating factor- and tumor necrosis factor alpha-mediated matrix metalloproteinase production by human osteoblasts and monocytes after infection with Brucella abortus. Infect Immun (2010) 0.91
Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA. Vaccine (2002) 0.91
Diagnostic usefulness of antibodies against ribosome recycling factor from Brucella melitensis in human or canine brucellosis. Clin Diagn Lab Immunol (2002) 0.91
Crystallographic studies on decameric Brucella spp. Lumazine synthase: a novel quaternary arrangement evolved for a new function? J Mol Biol (2005) 0.91
Brucella outer membrane protein Omp31 is a haemin-binding protein. Microbes Infect (2006) 0.91
Potential role of fibroblast-like synoviocytes in joint damage induced by Brucella abortus infection through production and induction of matrix metalloproteinases. Infect Immun (2011) 0.91
Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-α. Gene (2012) 0.90
Macrophage-elicited osteoclastogenesis in response to Brucella abortus infection requires TLR2/MyD88-dependent TNF-α production. J Leukoc Biol (2011) 0.90
Characteristics and role of the exocellular polysaccharides produced by five cyanobacteria isolated from phototrophic biofilms growing on stone monuments. Biofouling (2012) 0.90
The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams. Vaccine (2009) 0.90
Llama single domain antibodies as a tool for molecular mimicry. J Mol Biol (2005) 0.90
Smooth Brucella strains invade and replicate in human lung epithelial cells without inducing cell death. Microbes Infect (2009) 0.89
Single-domain llama antibodies as specific intracellular inhibitors of SpvB, the actin ADP-ribosylating toxin of Salmonella typhimurium. FASEB J (2010) 0.89
Outer membrane vesicles from Brucella abortus promote bacterial internalization by human monocytes and modulate their innate immune response. PLoS One (2012) 0.89
Toll-like receptor 6 plays an important role in host innate resistance to Brucella abortus infection in mice. Infect Immun (2013) 0.88
Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity. Microbes Infect (2006) 0.88
Confronting the barriers to develop novel vaccines against brucellosis. Expert Rev Vaccines (2011) 0.87
Affinity maturation increases the stability and plasticity of the Fv domain of anti-protein antibodies. J Mol Biol (2007) 0.87
Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus. Microbes Infect (2008) 0.87
Light regulates attachment, exopolysaccharide production, and nodulation in Rhizobium leguminosarum through a LOV-histidine kinase photoreceptor. Proc Natl Acad Sci U S A (2012) 0.87
Immunization with a chimera consisting of the B subunit of Shiga toxin type 2 and brucella lumazine synthase confers total protection against Shiga toxins in mice. J Immunol (2013) 0.86
Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies. PLoS One (2008) 0.86
The β-scaffold of the LOV domain of the Brucella light-activated histidine kinase is a key element for signal transduction. J Mol Biol (2012) 0.86
Sequence determinants of quaternary structure in lumazine synthase. Mol Biol Evol (2003) 0.85
Structure of the mature ectodomain of the human receptor-type protein-tyrosine phosphatase IA-2. J Biol Chem (2007) 0.85
Brucella abortus induces intracellular retention of MHC-I molecules in human macrophages down-modulating cytotoxic CD8(+) T cell responses. Cell Microbiol (2012) 0.85